GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bedrocan Cannabis Corp (FRA:8BC) » Definitions » Capex-to-Revenue

Bedrocan Cannabis (FRA:8BC) Capex-to-Revenue : 4.59 (As of Apr. 2015)


View and export this data going back to . Start your Free Trial

What is Bedrocan Cannabis Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Bedrocan Cannabis's Capital Expenditure for the three months ended in Apr. 2015 was €-1.52 Mil. Its Revenue for the three months ended in Apr. 2015 was €0.33 Mil.

Hence, Bedrocan Cannabis's Capex-to-Revenue for the three months ended in Apr. 2015 was 4.59.


Bedrocan Cannabis Capex-to-Revenue Historical Data

The historical data trend for Bedrocan Cannabis's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bedrocan Cannabis Capex-to-Revenue Chart

Bedrocan Cannabis Annual Data
Trend Jan13 Jan14 Jan15
Capex-to-Revenue
- - -

Bedrocan Cannabis Quarterly Data
Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 4.59

Competitive Comparison of Bedrocan Cannabis's Capex-to-Revenue

For the Biotechnology subindustry, Bedrocan Cannabis's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bedrocan Cannabis's Capex-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bedrocan Cannabis's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Bedrocan Cannabis's Capex-to-Revenue falls into.



Bedrocan Cannabis Capex-to-Revenue Calculation

Bedrocan Cannabis's Capex-to-Revenue for the fiscal year that ended in Jan. 2015 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 0
=N/A

Bedrocan Cannabis's Capex-to-Revenue for the quarter that ended in Apr. 2015 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-1.516) / 0.33
=4.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bedrocan Cannabis  (FRA:8BC) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Bedrocan Cannabis Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Bedrocan Cannabis's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Bedrocan Cannabis (FRA:8BC) Business Description

Traded in Other Exchanges
N/A
Address
POCML 2 Inc is a capital pool company. The Company will not carry on any business other than the identification and evaluation of assets or businesses with a view to completing a proposed Qualifying Transaction.

Bedrocan Cannabis (FRA:8BC) Headlines

No Headlines